mulberroside B

CAS No. 75872-12-7

mulberroside B( —— )

Catalog No. M19082 CAS No. 75872-12-7

Antitussive, antiasthmatic, hypoglycemic, anti - tumor, treatment of gout.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 284 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    mulberroside B
  • Note
    Research use only, not for human use.
  • Brief Description
    Antitussive, antiasthmatic, hypoglycemic, anti - tumor, treatment of gout.
  • Description
    Antitussive, antiasthmatic, hypoglycemic, anti - tumor, treatment of gout.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    p38 MAPK
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    75872-12-7
  • Formula Weight
    356.28
  • Molecular Formula
    C15H16O10
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O[C@H]1[C@H](OC2=C(O)C(O3)=C(C=C2O)C=CC3=O)O[C@H](CO)[C@@H](O)[C@@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Maohuoside A

    Maohuoside A promotes osteogenesis of rat mesenchymal stem cells via BMP and MAPK signaling pathways.

  • JNJ-49095397

    JNJ-49095397 (RV-568) is a specific narrow-spectrum kinase inhibitor that inhibits a selected set of kinases involved in COPD inflammation with IC50 of 5, 40 and 52 nM for p38α, p38γ and HCK, respectively.

  • UK 383367

    UK-383367 is a procollagen C-proteinase inhibitor with IC50 of 44 nM, has excellent selectivity over MMPs.